CAPECITABINE PLUS OXALIPLATIN (CAPOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN STAGE III COLON CANCER: A COST-MINIMIZATION ANALYSIS BASED ON REAL WORLD COSTS IN THE NETHERLANDS

被引：0
|
作者：
van Gils, C. W. M. [1 ]
de Groot, S. [1 ]
Redekop, W. K. [1 ]
Uyl-De Groot, C. A. [1 ]
机构：
[1] Inst Med Techonol Assessment, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1207
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A453 / A453
页数：1
相关论文
共 50 条
  • [41] Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer:: A planned safety analysis in 1,864 patients
    Schmoll, Hans-Joachim
    Cartwright, Thomas
    Tabernero, Josep
    Nowacki, Marek P.
    Figer, Arie
    Maroun, Jean
    Price, Timothy
    Lim, Robert
    Van Cutsem, Eric
    Park, Young-Suk
    McKendrick, Joseph
    Topham, Claire
    Soler-Gonzalez, Gemma
    de Braud, Filipo
    Hill, Mark
    Sirzen, Florin
    Haller, Daniel G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 102 - 109
  • [42] Capecitabine plus oxaliplatin (XELOX) versus bolus 5-fluorouracil/leucovorin (5-FU/LV) as adjuvant therapy for stage III colon cancer: Survival follow-up of study NO16968 (XELOXA).
    Schmoll, Hans-Joachim
    Tabernero, Josep
    Maroun, Jean Alfred
    De Braud, Filippo G.
    Price, Timothy Jay
    Van Cutsem, Eric
    Hill, Mark
    Hoersch, Silke
    Rittweger, Karen
    Haller, Daniel G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [43] Comparison of adverse events during capecitabine versus 5-fluorouracil/oxaliplatin adjuvantchemotherapy for stage II/III colon cancer: A population based analysis.
    Pabani, Aliyah
    Mazurek, Matthew
    Cheung, Winson Y.
    Spratlin, Jennifer L.
    Hiller, Julie A. Price
    Standeven, Leah Jean
    Mulder, Karen E.
    Ghosh, Sunita
    Ho, Maria Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] COST-EFFECTIVENESS ANALYSIS OF OXALIPLATIN PLUS FLUOROURACIL/LEUCOVORIN (FOLFOX4) COMPARED TO SORAFENIB FOR TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA PATIENTS IN CHINA
    Qin, S. K.
    Kruger, E.
    Tan, S. C.
    Cheng, S. Q.
    Yao, X. X.
    Liang, J.
    VALUE IN HEALTH, 2016, 19 (07) : A889 - A889
  • [45] Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial
    Schmoll, Hans-Joachim
    Tabernero, Josep
    Maroun, Jean
    de Braud, Filippo
    Price, Timothy
    Van Cutsem, Eric
    Hill, Mark
    Hoersch, Silke
    Rittweger, Karen
    Haller, Daniel G.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3733 - +
  • [46] Cardiac metastasis from colon cancer effectively treated with 5-fluorouracil, leucovorin, and oxaliplatin (modified FOLFOX6) plus panitumumab: a case report
    Yoshiki Tsujii
    Yoshito Hayashi
    Akira Maekawa
    Tetsuji Fujinaga
    Kengo Nagai
    Shunsuke Yoshii
    Akihiko Sakatani
    Satoshi Hiyama
    Shinichiro Shinzaki
    Hideki Iijima
    Tetsuo Takehara
    BMC Cancer, 17
  • [47] Cardiac metastasis from colon cancer effectively treated with 5-fluorouracil, leucovorin, and oxaliplatin (modified FOLFOX6) plus panitumumab: a case report
    Tsujii, Yoshiki
    Hayashi, Yoshito
    Maekawa, Akira
    Fujinaga, Tetsuji
    Nagai, Kengo
    Yoshii, Shunsuke
    Sakatani, Akihiko
    Hiyama, Satoshi
    Shinzaki, Shinichiro
    Iijima, Hideki
    Takehara, Tetsuo
    BMC CANCER, 2017, 17
  • [48] Adjuvant 5-Fluorouracil/leucovorin, capecitabine, and oxaliplatin-related regimens for stage II/III colon cancer patients 66 years or older
    Jones, Emily
    Duan, Zhigang
    Nguyen, Thinh T.
    Giordano, Sharon H.
    Zhao, Hui
    CANCER MEDICINE, 2023, 12 (03): : 2389 - 2406
  • [49] Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer
    Bai, Liangliang
    Zhang, Pengfei
    Zhou, Kexun
    Liao, Weiting
    Li, Qiu
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10419 - 10426
  • [50] Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401
    Pasquale Comella
    Bruno Massidda
    Gianfranco Filippelli
    Antonio Farris
    Donato Natale
    Giuseppe Barberis
    Luigi Maiorino
    Sergio Palmeri
    Michele Cannone
    Giovanni Condemi
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 217 - 226
12345